06 June 2017
Dechra Veterinary Products has rolled out the use of its popular titratable analgesic for dogs and cats - Comfortan- to the Republic of Ireland
Comfortan can be used as an analgesic also as a premedication for general anaesthesia or neuroleptanalgesia in dogs and cats when used in combination with a neuroleptic. The active ingredient is methadone hydrochloride and it is available in 5 ml and 10 ml vials.
Comfortan was the first vet-licensed methadone in the UK and it has recently been licensed for use in Ireland.
Dechra has unveiled new resources for veterinary professionals to support the launch including controlled drug registers, pain scales, pain scoring charts and access to a webcast on The Role of Methadone in Pain Management.
Comfortan is one of a range of products in Dechra's anaesthesia and analgesia portfolio which also includes Anesketin® and Buprenodale®. It is licensed for IM, IV, and SC usage in dogs and IM in cats.
Dechra Brand Manager Craig Sankey said: “Comfortan has become one of our most popular analgesia products since it was launched in the UK several years ago so we are delighted to be able to add it to our portfolio of products in the ROI.
“The 5 ml bottle is a great size for practices that would like to introduce Comfortan into their practice protocols, allowing them to do so in a cost-effective way. They can trade up to the 10 ml bottle once they start to use it on more cases.”
Comfortan is available from veterinary wholesalers. For further information, contact your Dechra Veterinary Products Sales Manager or visit www.dechra.ie.
Comfortan introduced to ROI market